Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: Art M who wrote (632)	1/6/2004 10:21:19 AM
From: tuck	Read Replies (1) \| Respond to of 897

Adding NGEN to the WatchList and seriously considering a position. The run up from their nanotech patent seems quite overdone to me, since it will be years before they or anyone have a chance of putting it to commercial use. Meanwhile their SNP diagnostic business languishes due to slow roll out of products. If they don't do a follow on here, the CFO should be fired. Anybody got thoughts? Bernard picked this for his 04 contest, and it's currently his biggest winner, but I suspect it was a technical breakout pick more than a fundamental one. He doesn't hang out here, anyway. But Bernard -- and other biofreaks -- if you're out there, comments welcome. Aside to gotmojo. Looks like CYPB is being stubborn at the moment. What's your reasoning and timeframe? Cheers, Tuck